| 36343786 | UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways. | Cancer Lett | 2023 |
| 37717923 | Nested and Large Nested Subtypes of Urothelial Carcinoma of the Upper Urinary Tract: A Multi-institutional Study. | Mod Pathol | 2023 |
| 38020525 | Feasibility and Impact of Immunohistochemistry-based Molecular Subtyping for Muscle-invasive Bladder Cancer in Patients Treated with Radiation-based Therapy. | Eur Urol Open Sci | 2023 |
| 37680023 | ABCC2 brush-border expression predicts outcome in papillary renal cell carcinoma: a multi-institutional study of 254 cases. | Histopathology | 2023 |
| 37126232 | Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance. | J Urol | 2023 |
| 37073437 | Cell-by-cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression. | J Pathol Clin Res | 2023 |
| 37037938 | A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients. | Br J Cancer | 2023 |
| 36562104 | A Sarcomatoid Renal Cell Carcinoma with Clear Cell Papillary-Like Primary Tumor and Lymph Node Metastasis: A Diagnostic Conundrum. | Int J Surg Pathol | 2023 |
| 35901948 | The Rate of Prostatic Involvement in Men Treated With Radical Cystectomy for Muscle Invasive Bladder Cancer. | Pract Radiat Oncol | 2023 |
| 34728788 | Correction to: Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases. | Mod Pathol | 2022 |
| 35411033 | Fatty acid oxidation enzyme ο3, ο2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate cancer patients. | Oncogene | 2022 |
| 35490858 | Morphologic alterations post trimodal therapy in muscle-invasive urothelial carcinoma: understanding the impact of post-treatment changes on the pathological interpretation and their potential clinical correlates. | Hum Pathol | 2022 |
| 35900850 | Clinicopathologic Spectrum of Secondary Solid Tumors of the Prostate of Nonurothelial Origin: Multi-institutional Evaluation of 85 Cases. | Am J Surg Pathol | 2022 |
| 36353066 | Impact of Programmed Death-ligand 1 Expression on Oncological Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Radiation-based Therapy. | Eur Urol Open Sci | 2022 |
| 34949766 | Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients. | Mod Pathol | 2022 |
| 34958810 | ABCC2 expression in papillary renal cell carcinoma provides better prognostic stratification than WHO/ISUP nucleolar grade. | Hum Pathol | 2022 |
| 34862117 | Impact of sarcopenia on outcomes of patients treated with trimodal therapy for muscle invasive bladder cancer. | Urol Oncol | 2022 |
| 34521993 | Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases. | Mod Pathol | 2022 |
| 32948433 | Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey. | Urol Oncol | 2021 |
| 33620995 | Erectile function after partial penectomy for penile cancer. | Int Braz J Urol | 2021 |
| 35099374 | Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer - Abridged version. | Can Urol Assoc J | 2021 |
| 35098169 | Role of Serum Lymphocyte-derived Biomarkers in Nonmetastatic Muscle-invasive Bladder Cancer Patients Treated with Trimodal Therapy. | Eur Urol Open Sci | 2021 |
| 34611304 | Correction to: Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases. | Mod Pathol | 2021 |
| 34830979 | Rational Development of Liquid Biopsy Analysis in Renal Cell Carcinoma. | Cancers (Basel) | 2021 |
| 33938798 | Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer - Full-text. | Can Urol Assoc J | 2021 |
| 34128484 | The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers. | Adv Anat Pathol | 2021 |
| 34128483 | The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia. | Adv Anat Pathol | 2021 |
| 33986291 | Role of neutrophil extracellular traps in radiation resistance of invasive bladder cancer. | Nat Commun | 2021 |
| 33283758 | Refining assessment of response to radiation-based therapy for muscle-invasive bladder cancer: Is post-treatment tumor bed biopsy always necessary? | Urol Oncol | 2021 |
| 33421558 | Phase 1 Trial of Atezolizumab Plus Trimodal Therapy in Patients With Localized Muscle-Invasive Bladder Cancer. | Int J Radiat Oncol Biol Phys | 2021 |
| 33071190 | Evidence-based diagnostic accuracy measurement in urine cytology using likelihood ratios. | J Am Soc Cytopathol | 2021 |
| 32589068 | The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer. | Arch Pathol Lab Med | 2021 |
| 32453694 | Continuing towards optimization of bladder cancer care in Canada: Summary of the third Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meeting. | Can Urol Assoc J | 2020 |
| 31915958 | Dataset for the reporting of carcinoma of the bladder-cystectomy, cystoprostatectomy and diverticulectomy specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR). | Virchows Arch | 2020 |
| 31821734 | Do we need PD-L1 as a biomarker for thyroid cytologic and histologic specimens? | Cancer Cytopathol | 2020 |
| 32763409 | Design and Development of a Fully Synthetic Multiplex Ligation-Dependent Probe Amplification-Based Probe Mix for Detection of Copy Number Alterations in Prostate Cancer Formalin-Fixed, Paraffin-Embedded Tissue Samples. | J Mol Diagn | 2020 |
| 32568842 | Metastatic Prostatic Adenocarcinoma in Patient With Muir-Torre Syndrome Misdiagnosed as Metastatic Sebaceous Carcinoma: Case Report and Systematic Literature Review. | Am J Dermatopathol | 2020 |
| 30467243 | Revitalising an academic pathology department: lessons learnt. | J Clin Pathol | 2019 |
| 30218308 | SIU-ICUD on bladder cancer: pathology. | World J Urol | 2019 |
| 30140035 | The combination of PTEN deletion and 16p13.3 gain in prostate cancer provides additional prognostic information in patients treated with radical prostatectomy. | Mod Pathol | 2019 |
| 30113732 | Optimization of the 2014 Gleason grade grouping in a Canadian cohort of patients with localized prostate cancer. | BJU Int | 2019 |
| 30136199 | The relationship between body-mass index, physical activity, and pathologic and clinical outcomes after radical prostatectomy for prostate cancer. | World J Urol | 2019 |
| 31381885 | Integrated Molecular Analysis of Papillary Renal Cell Carcinoma and Precursor Lesions Unfolds Evolutionary Process from Kidney Progenitor-Like Cells. | Am J Pathol | 2019 |
| 31433512 | A three-gene DNA methylation biomarker accurately classifies early stage prostate cancer. | Prostate | 2019 |
| 31231128 | Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma. | Mod Pathol | 2019 |
| 31340802 | Improving ultrasound-based prostate volume estimation. | BMC Urol | 2019 |
| 31192862 | Data Set for the Reporting of Carcinoma of the Renal Pelvis and Ureter-Nephroureterectomy and Ureterectomy Specimens: Recommendations From the International Collaboration on Cancer Reporting (ICCR). | Am J Surg Pathol | 2019 |
| 31009090 | Dataset for reporting of carcinoma of the urethra (in urethrectomy specimens): recommendations from the International Collaboration on Cancer Reporting (ICCR). | Histopathology | 2019 |
| 31002177 | High-grade oncocytic tumour (HOT) of kidney in a patient with tuberous sclerosis complex. | Histopathology | 2019 |
| 28753789 | Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy. | Eur Urol Focus | 2018 |